AI Summary
We reviewed 10 live results for zarzio (filgrastim) and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are G Csf and Biopharmaceuticals.
Comparison Table
Recommended
Zarzio (Filgrastim)
Source: Sandoz Philippines Corporation
Description
Zarzio is a biosimilar immunostimulant belonging to the colony-stimulating factor class, specifically used to manage neutropenia in patients undergoing medical treatments.
Best for
oncology support, neutropenia treatment, chemotherapy patients and white blood cell stimulation
View Details
Rating
Zarzio (filgrastim)
Source: Novartis (Thailand) Limited
Description
Zarzio is a biosimilar granulocyte-colony stimulating factor (G-CSF) used to stimulate the production of white blood cells in patients undergoing chemotherapy or bone marrow transplants. It is specifically formulated to prevent neutropenia and subsequent infections, available as a solution for injection or infusion.
Best for
oncology patients, infection prevention, chemotherapy support and Thai healthcare facilities
View Details
Rating
Neupogen (filgrastim)
Source: Amgen
Description
Neupogen is the reference biologic (originator) medication containing recombinant filgrastim. It is used to stimulate bone marrow to produce white blood cells to prevent infections in patients with non-myeloid malignancies receiving myelosuppressive therapy.
Best for
reference biologic preference, established clinical protocols, severe chronic neutropenia and specialized oncology clinics
View Details
Rating
| Compare | Zarzio (Filgrastim) | Zarzio (filgrastim) | Neupogen (filgrastim) |
|---|---|---|---|
| Source | Sandoz Philippines Corporation | Novartis (Thailand) Limited | Amgen |
| Description | Zarzio is a biosimilar immunostimulant belonging to the colony-stimulating factor class, specifically used to manage neutropenia in patients undergoing medical treatments. | Zarzio is a biosimilar granulocyte-colony stimulating factor (G-CSF) used to stimulate the production of white blood cells in patients undergoing chemotherapy or bone marrow transplants. It is specifically formulated to prevent neutropenia and subsequent infections, available as a solution for injection or infusion. | Neupogen is the reference biologic (originator) medication containing recombinant filgrastim. It is used to stimulate bone marrow to produce white blood cells to prevent infections in patients with non-myeloid malignancies receiving myelosuppressive therapy. |
| Best for | oncology support, neutropenia treatment, chemotherapy patients and white blood cell stimulation | oncology patients, infection prevention, chemotherapy support and Thai healthcare facilities | reference biologic preference, established clinical protocols, severe chronic neutropenia and specialized oncology clinics |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Zarzio (Filgrastim) from Sandoz Philippines Corporation."
I picked this because Zarzio is a well-established biosimilar in the Philippines, authorized since 2017 for effective neutropenia management.
Share this search
Related Finds